Interaction of eukaryotic initiation factor 5A with the human immunodeficiency virus type 1 rev response element RNA and U6 snRNA requires deoxyhypusine or hypusine modification

NeuroSignals

Volumn 6, Issue 3, 1997, Pages 166-174

  Liu, Yi Ping ^a   Nemeroff, Martin ^a   Yan, Yong Ping ^a   Chen, Kuang Yu ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

Deoxyhypusine; Eukaryotic initiation factor 5A; Hypusine; Rev; RNA

Indexed keywords

DEOXYHYPUSINE; HYPUSINE; INITIATION FACTOR; INITIATION FACTOR 5A; REV PROTEIN; REX PROTEIN; RNA BINDING PROTEIN; SMALL NUCLEAR RNA; SYNTHETASE; UNCLASSIFIED DRUG; VIRUS RNA;

AMINO TERMINAL SEQUENCE; ARCHAEBACTERIUM; ARTICLE; CELL DEATH; CELL GROWTH; CONTROLLED STUDY; EUKARYOTIC CELL; GEL MOBILITY SHIFT ASSAY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1; NONHUMAN; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN RNA BINDING; PROTEIN SYNTHESIS;

GENE PRODUCTS, REV; HIV-1; HUMANS; LYSINE; PEPTIDE INITIATION FACTORS; PROTEIN BINDING; RNA, SMALL NUCLEAR; RNA, VIRAL; RNA-BINDING PROTEINS; VIRUS REPLICATION;

ARCHAEA; EUKARYOTA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 0030863875     PISSN: 1424862X     EISSN: 14248638     Source Type: Journal    
DOI: 10.1159/000109123     Document Type: Article

References (34)

1. Park MH. Wolf TEC, Folk JE: Hypu-sine: Its post-translational formation in eukaryotic initiation factor 5A and its potential role in cellular regulation. Biofactors 1993;4:95-104.
2. Cooper HL, Park MH, Folk JE: Posttranslational formation of hy-pusine in a single major protein occurs generally in growing cells and is associated with activation of lymphocyte growth. Cell 1982:29:791 -797.
3. Chen KY: An 18,000-dalton protein metabolically labeled by polyamines in various mammalian cell lines. Biochim Biophys Acta 1983;756: 395-402.
4. Cohen SS: Introduction to Polyamines. New Jersey, Prentice-Hall, 1971, pp 1-179.
5. Tabor CW, Tabor H: Polyamines. Annu Rev Biochem 1984;53:749-790.
6. Pegg AE: Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res 1988;48:759-774.
7. Schnier J, Schwelberger HG, Smit-McBride Z, Kang HA, Hershey JWB: Translation initiation factor 5A and its hypusine modification arc essential for cell viability in the yeast Saccharomyces cerevisiae. Mol Cell Biol 1991;11:3105-3114.
8. Sasaki K, Abid MR, Miyazaki M: Dcoxyhypusine synthase gene is essential for cell viability in the yeast Saccharomyces cerevisiae. FEBS Lett 1996;384:151-154.
9. Benne R, Brown-Luedc M, Hershey JWB: Purification and characterization of protein synthesis initiation factors eIF-1, eIF-4C, eIF-4D, and eIF-5 from rabbit reticulocytes. J Biol Chem 1978;253:3070-3077.
10. Park MH: The essential role of hypusine in eukaryotic translation initiation factor 4D (elF-4D). Purification of elF-4D and its precursors and comparison of their activities. J Biol Chem 1989;264:18531-18535.
11. Smit-McBride Z, Schnier J, Kaufman RJ, Hershey B: Protein synthesis initiation factor elF-4D. Functional comparison of native and un-hypusinated forms of the protein. J Biol Chem 1989;264:18527-18530.
12. Kang HA, Hershey JWB: Effect of initiation factor elF-5A depletion on protein synthesis and proliferation of Saccharomyces cerevisiae. J Biol Chem 1994;269:3934-3940.
13. Duncan RF, Hershey JW: Changes in eIF-4D hypusine modification or abundance are not correlated with translational repression in HeLa cells. J Biol Chem 1986;261:12903-12906.
14. Gordon ED, Mora R, Meredith SC, Lindquist SL: Hypusine formation in eukaryotic initiation factor 4D is not reversed when rates or specificity of protein synthesis is altered. J Biol Chem 1987;262:16590-16595.
15. Ruh IM, Himmelspach M. Bahr GM, Himmerschmid F, Jaksche H, Wolff B, Aschauer H, Farrington GK, Probst H, Bevec D, Hauber J: Eukaryotic initiation factor 5 A is a cellular target of the human immunodeficiency virus type I Rev activation domain mediating trans-activation. J Cell Biol 1993;123:1309-1320.
16. Cullen BR: Regulation of human immunodeficiency virus replication. Annu Rev Microbiol 1991; 380:209-214.
17. Jones KA, Peterlin BM: Control of RNA initiation and elongation at the HIV-1 promoter. Annu Rev Bio-chem 1994;63:717-743.
18. Katahira J, Ishizaki T, Sakai H, Ad-achi A, Yamamoto K, Shida H: Effects of translational initiation factor cIF-5A on the functioning of human T-cell leukemia virus type 1 Rex and human immunodeficiency virus Rev inhibited trans-dominant-ly by a Rex mutant deficient in RNA binding. J Virol 1995;69:3125-3133.
19. Lejbkowiez F, Goyer C, Darvcau A, Neron S, Lemieux R, Sonenberg N: A fraction of the mRNA 5' cap-binding protein, eukaryotic initiation factor 4E, localizes to the nucleus. Proc Natl Acad Sci USA 1992; 89:9612-9616.
20. McBratney S, Chen CY, Samow P: Internal initiation of translation. Curr Opin Cell Biol 1993;5:S61-965.
21. Malim MH, Tiley LS, McCam DF, Rusche JR, Hauber J, Cullen BR: HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence. Cell 1990;60:675-683.
22. Qiu Y, Nemeroff M, Krug RM: The influenza virus NS1 protein binds to a specific region in human U6 snRNA and inhibits U6-U2 andU6-U4 snRNA interactions during splicing. RNA 1996;1:304-316.
23. Hcaphy S, Dingwall C, Emberg I, Gait M, Green SM, Kam J, Lowe AD, Singh M, Skinner MA: HIV-1 regulator of viron expression (Rev) protein binds to an RNA stem loop structure located within the Rev response element region. Cell 1990; 60:685-693.
24. Tao Y, Chen KY: PCR-bascd cloning of the full-length Neurospora eukaryotic initiation factor 5A cDNA: Polvhistidine-tagging and overexpression for protein affinity binding. Biochem J 1994:302:517-525.
25. Klier H, Csonga R, Joao HC, Eck-erskom C, Auer M, Lottspeich F, Eder J: Isolation and structural characterization of different isoforms of the hypusine-containing protein c!F-5A from HcLa cells. Biochemistry 1995;34:14693-14702.
26. Dingall C, Laskey RA: Nuclear targeting sequence - a consensus? TIBS 1991;16:478-481.
27. Fisher U, Huber J, Boelens WC, Mattaj IW, Luhrmann R: The HIV-I Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 1995;82:475-483.
28. Wen W, Meinkoth JL, Tsien RY, Taylor SS: Identification of a signal for rapid export of proteins from the nucleus. Cell 1995;82:463-473.
29. Kobe B, Deisenhofer J: The leucine-rich repeat: A versatile binding motif. Trends Biochem Sci 1994; 19: 415-420.
30. Bevec D, Jaschc H, Oft M, Wohl T, Himmelspach M, Pacher A, Sche-besta M, Koettnitz K, Dobrovnik M, Csonga R. Lottspeich F, Hauber J: Inhibition of HIV-1 replication in lymphocytes by mutants of the Rev cofactor e!F-5A. Science 1996;27T. 1858-1862.
31. Pochon F, Cohen SS: 4-Thiouridinc and the conformation of E. coli tRNA induced by spermidine. Bio-chem Biophys Res Commun 1973; 47:720-726.
32. Malim MH, Cullen BR: HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: Implications for HIV-1 latency. Cell 1991;65: 241-248.
33. Qiu Y, Krug RM: The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear transport of mRNAs containing poly(A). J Virol 1994;68:2425-2432.
34. Qian X-Y, Alonso-Caplen F, Krug RM: Two functional domains of the influenza virus NS1 protein are required for regulation of nuclear export of mRNA. J Virol 1994:68: 2433-2441.